Skip to main content
. 2011 Jul 19;134(8):2339–2357. doi: 10.1093/brain/awr165

Figure 7.

Figure 7

Vandetanib co-treatment blocked l-dopa-induced angiogenic activity in the basal ganglia. Endothelial proliferation (BrdU+/Laminin+ cells) (A), nestin upregulation (B), downregulation of endothelial barrier antigen (EBA; C), and parenchymal albumin extravasation (D). l-dopa + vehicle (n = 12), l-dopa + vandetanib (n = 10), saline (n = 12). One-factor ANOVA followed by post hoc Student–Newman–Keul’s. P < 0.05 *versus saline controls, # versus l-dopa + vandetanib.